BRIEF-Sanofi's new basal insulin lantus xr aproved in Japan
July 03, 2015 at 02:12 AM EDT
* Says new basal insulin lantus xr, known as toujeo in the u.s. and Europe approved in Japan for the treatment of diabetes mellitus. Source text for Eikon: Further company coverage: (Reporting By Dominique Vidalon)
